| Literature DB >> 25820824 |
Jianguo Zhang1, Junya Zhu2, Lei Yang2, Chengqi Guan2, Runzhou Ni2, Yuchan Wang2, Lili Ji2, Ye Tian3.
Abstract
CtBP2, as a transcriptional corepressor of epithelial-specific genes, has been reported to promote tumor due to upregulating epithelial-mesenchymal transition (EMT) in cancer cells. CtBP2 was also demonstrated to contribute to the proliferation of esophageal squamous cell carcinoma (ESCC) cells through a negative transcriptional regulation of p16(INK4A). In this study, for the first time, we reported that CtBP2 expression, along with CCNH/CDK7, was higher in ESCC tissues with lymph node metastases than in those without lymph node metastases. Moreover, both CtBP2 and CCNH/CDK7 were positively correlated with E-cadherin, tumor grade, and tumor metastasis. However, the concrete mechanism of CtBP2's role in enhancing ESCC migration remains incompletely understood. We confirmed that CCNH/CDK7 could directly interact with CtBP2 in ESCC cells in vivo and in vitro. Furthermore, our data demonstrate for the first time that CtBP2 enhanced the migration of ESCC cells in a CCNH/CDK7-dependent manner. Our results indicated that CCNH/CDK7-CtBP2 axis may augment ESCC cell migration, and targeting the interaction of both may provide a novel therapeutic target of ESCC.Entities:
Keywords: C-terminal binding protein 2 (CtBP2); Cyclin H (CCNH); Cyclin-dependent kinase 7 (CDK7); Epithelial-mesenchymal transition (EMT); Esophageal squamous cell carcinoma (ESCC); Metastasis
Mesh：
Substances：
Year: 2015 PMID： 25820824 DOI： 10.1007/s13277-015-3354-x
Source DB: PubMed Journal: Tumour Biol ISSN： 1010-4283